How Beta Bionics, Inc. stacks up

BBNX · against 480 other Healthcare companies of similar size

Profitability

19/ 100

Near the bottom of its peers.

Ranked #398 of 481 · scores higher than 16% of peers

Bars: peers in each 10-point band of the profitability score

50 peers with a profitability score of 10–19, including BBNX · Click a bar to see the companies

Why profitability scores 19?

Weighted metrics compared with all Healthcare companies.

Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.

a thinner operating margin: weaker than 85% of peers. Operating margin: -69.8% vs peer median 7.1%
a lower return on assets: weaker than 84% of peers. Return on assets: -25.0% vs peer median 1.7%
a lower return on invested capital: weaker than 83% of peers. Return on invested capital: -30.9% vs peer median 4.7%

Metric by metric

Position: dot = BBNX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	BBNX	Peer median	Better than	Weight
Return on invested capitalHigher is better · 455 reported	-30.9%	3.6%	15%	33%
Operating marginHigher is better · 449 reported	-69.8%	5.6%	11%	33%
Return on assetsHigher is better · 474 reported	-25.0%	1.4%	14%	33%
Return on equityHigher is better · 454 reported	-26.2%	2.1%	20%	Context only
Gross marginHigher is better · 497 reported	58.3%	43.9%	66%	Context only

Ranking by profitability score

Top 5 and the companies ranked around BBNX

Rank	Company	Market cap	Profitability	Overall
1	Procter & Gamble Health LimitedPGHL.NS · India	97.3B INR (≈$1.2B)	100	80
2	Arbutus Biopharma CorporationABUS · US-listed	595M USD	99	97
2	CorMedix Inc.CRMD · US-listed	433M USD	99	81
2	Ironwood Pharmaceuticals, Inc.IRWD · US-listed	578M USD	99	73
2	MeiraGTx Holdings plcMGTX · US-listed	914M USD	99	81
⋯
394	China Reform Health Management and Services Group Co., Ltd.000503.SZ · China	6.8B CNY (≈$947M)	21	27
394	Climb Bio, Inc.CLYM · US-listed	560M USD	21	42
394	Evolent Health, Inc.EVH · US-listed	486M USD	21	16
397	The Oncology Institute, Inc.STLN · US-listed	646M USD	20	46
398	Beta Bionics, Inc.BBNX · US-listed	815M USD	19	53
398	Design Therapeutics, Inc.DSGN · US-listed	647M USD	19	40
398	908 Devices Inc.MASS · US-listed	441M USD	19	34
398	Nanobiotix S.A.NBTX · US-listed	1.5B USD	19	32
398	Pacific Biosciences of California, Inc.PACB · US-listed	758M USD	19	35

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…